162 related articles for article (PubMed ID: 32550169)
1. Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study.
Bahar A; Kashi Z; Kheradmand M; Hedayatizadeh-Omran A; Moradinazar M; Ramezani F; Afshari M; Moosazadeh M
J Diabetes Metab Disord; 2020 Jun; 19(1):205-211. PubMed ID: 32550169
[TBL] [Abstract][Full Text] [Related]
2. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
Herrera-Enriquez K; Narvaez-Guerra O
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome: a population-based study of prevalence and risk factors.
Jamali Z; Ayoobi F; Jalali Z; Bidaki R; Lotfi MA; Esmaeili-Nadimi A; Khalili P
Sci Rep; 2024 Feb; 14(1):3987. PubMed ID: 38368464
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China.
Cheng L; Yan W; Zhu L; Chen Y; Liu J; Xu Y; Ji L; He J
PLoS One; 2017; 12(12):e0189046. PubMed ID: 29216328
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
Zabetian A; Hadaegh F; Azizi F
Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
Bee YT; Haresh KK; Rajibans S
Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
[TBL] [Abstract][Full Text] [Related]
8. Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population.
Sun F; Gao B; Wang L; Xing Y; Ming J; Zhou J; Fu J; Li X; Xu S; Liu G; Ji Q
Diabetes Ther; 2018 Aug; 9(4):1457-1468. PubMed ID: 29808362
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil.
Espósito RC; de Medeiros PJ; Silva FS; Oliveira AG; Soares Aragão CF; Oliveira Rocha HA; Moreira SA; de Farias Sales VS
Diabetes Metab Syndr Obes; 2018; 11():401-408. PubMed ID: 30122967
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of metabolic syndrome according to various definitions and hypertriglyceridemic-waist in malaysian adults.
Zainuddin LR; Isa N; Muda WM; Mohamed HJ
Int J Prev Med; 2011 Oct; 2(4):229-37. PubMed ID: 22174962
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.
Hadaegh F; Zabetian A; Tohidi M; Ghasemi A; Sheikholeslami F; Azizi F
Ann Acad Med Singap; 2009 Feb; 38(2):142-9. PubMed ID: 19271043
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relationship between opioid addiction and metabolic syndrome and its components in the adult population from Rafsanjan city; a cohort study.
Bagheri-Hosseinabadi Z; Khalili P; Hakimi H; Jalali N; Abbasifard M
Inflammopharmacology; 2022 Dec; 30(6):2107-2116. PubMed ID: 36103030
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in type 2 diabetes: comparison of WHO, modified ATPIII & IDF criteria.
Ahmed A; Khan TE; Yasmeen T; Awan S; Islam N
J Pak Med Assoc; 2012 Jun; 62(6):569-74. PubMed ID: 22755342
[TBL] [Abstract][Full Text] [Related]
15. Which Criteria to Use to Identify Metabolic Syndrome among Patients with Addictive Disorders?: Observations among Patients with Alcohol and Opioid Dependence Syndrome.
Singh Balhara YP; Jain R; Kuppili PP; Shukla A; Chawla N; Gupta R
Indian J Endocrinol Metab; 2018; 22(4):565-568. PubMed ID: 30148108
[TBL] [Abstract][Full Text] [Related]
16. Index of central obesity as a parameter to replace waist circumference for the definition of metabolic syndrome in predicting cardiovascular disease.
Luo W; Guo Z; Wu M; Hao C; Zhou Z; Yao X
J Cardiovasc Med (Hagerstown); 2014 Oct; 15(10):738-44. PubMed ID: 24937473
[TBL] [Abstract][Full Text] [Related]
17. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
Assmann G; Guerra R; Fox G; Cullen P; Schulte H; Willett D; Grundy SM
Am J Cardiol; 2007 Feb; 99(4):541-8. PubMed ID: 17293200
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlates of metabolic syndrome among adults in freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria.
Russell JBW; Koroma TR; Sesay S; Samura SK; Lakoh S; Bockarie A; Abiri OA; Conteh V; Conteh S; Smith M; Mahdi OZ; Lisk DR
Int J Cardiol Cardiovasc Risk Prev; 2024 Mar; 20():200236. PubMed ID: 38299125
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.
Tauler P; Bennasar-Veny M; Morales-Asencio JM; Lopez-Gonzalez AA; Vicente-Herrero T; De Pedro-Gomez J; Royo V; Pericas-Beltran J; Aguilo A
PLoS One; 2014; 9(2):e89281. PubMed ID: 24586656
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
